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Abstract
While high-throughput genotyping technologies are becoming readily available, the merit of using
these technologies to perform genome-wide association studies has not been established. One
major concern is that for studies of complex diseases and traits, the whole-genome approach
requires such large sample sizes that both recruitment and genotyping pose considerable challenge.
Here we propose a novel statistical method that boosts the effective sample size by combining data
obtained from several studies. Specifically, we consider a situation in which various studies have
genotyped non-overlapping subjects at largely non-overlapping sets of markers. Our approach,
which exploits the local linkage disequilibrium structure without assuming an explicit population
model, opens up the possibility of improving statistical power by incorporating existing data into
future association studies.
Background
The past few years have seen a rapid development in high-
throughput genotyping platforms, making genome-wide
association studies technologically feasible. Yet the merit
of using these technologies to perform genome-wide asso-
ciation studies has not been established [1]. Insufficient
sample size is a particular concern in genome-wide asso-
ciation studies for several reasons. First, the genotyping
cost, even though decreasing, nonetheless puts a pressure
to reduce the number of individuals assayed. Second, the
sample size required to declare statistical significance is
increased as a result of the large number of hypotheses
tested. Third, a majority of these studies investigate com-
plex diseases, in which each disease variant confers a mod-
erate risk. Thus, assuming an odds ratio of 1.5 and an
allele frequency of 0.2, more than 1000 cases and controls
are required for a statistical power of 80% and a signifi-
cance level of p < 10-6 [2].
Several approaches are being developed to improve the
efficiency of genome-wide association studies. One attrac-
tive solution is a multi-stage design, in which only a sub-
set of individuals are genotyped at the full set of markers
in the initial phase. In subsequent stages, additional indi-
viduals are genotyped at increasingly restricted marker
sets [3]. In the context of family-based association testing,
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methods have also been developed that use the same data
for genomic screening and replication [4]. Both of these
methods focus on reducing the number of hypotheses
tested.
As an alternative, we note that association studies of some
diseases, such as rheumatoid arthritis (RA), are being per-
formed by more than one group of investigators, giving
rise to multiple data sets [5,6]. One major challenge is that
subjects from different studies, or within a study over the
study period, may be genotyped by different platforms;
therefore, different sets of single-nucleotide polymor-
phisms (SNPs) are assayed. In linkage analysis, it is rela-
tively straightforward to combine families genotyped at
different marker panels: a LOD score at an unobserved
marker may be evaluated using neighboring observed
markers through multipoint interval mapping techniques
[7]; LOD scores at corresponding genome locations can
then be added across families. In contrast, to our knowl-
edge, a multipoint interval mapping approach has not
been developed in the context of linkage disequilibrium
(LD) association studies. This is because without a priori
knowledge of LD patterns between markers, it is difficult
to infer LD between disease and an unobserved marker
based on neighboring observed markers. Furthermore,
haplotypes constructed on each study cannot be easily
combined. On the other hand, there is evidence that
strong LD exists among tightly linked markers, and there-
fore we expect the test statistics at these markers to be cor-
related [8].
In this paper, we propose a novel approach that allows us
to increase the effective sample size by combining data
obtained from several studies. Specifically, we consider a
situation in which both the subjects and marker panels
are non-overlapping among the studies. In this situation,
it is not possible to evaluate LD between markers from dif-
ferent panels. Our approach, which exploits the local LD
structure without assuming an explicit population model,
opens up the possibility of improving statistical power by
incorporating existing data into future association studies.
We illustrate our method by analyzing the simulated RA
data. We had no knowledge of the "answers" at the time
of analysis.
Methods
We have previously described a multipoint transmission-
disequilibrium test (TDT) method that is based on local
smoothing [8]. Our study demonstrated that a) TDT sta-
tistics at tightly linked markers are correlated, and b)
when tightly linked markers are genotyped, the smoothed
TDT statistics can achieve a greater statistical power com-
pared with the non-smoothed version. These findings sug-
gest that TDT statistics can be combined, even though the
different studies have genotyped non-overlapping set of
markers.
Combining data sets with non-overlapping markers and 
individuals
In this section, we outline our statistical methodology in
a simple setting: two studies have genotyped non-overlap-
ping sets of markers on independent sets of individuals in
a common genomic region, and both studies have used a
case-parents trio design. In each study, the TDT statistics,
TDTA or TDTB, can be computed at the genotyped markers
[9].
To motivate our test statistic, we first consider a marker
that has been genotyped in both studies. In Study A, let b1
denote the number of informative transmissions, in
which A alleles are transmitted but a alleles are not trans-
mitted, and let c1 denote the converse (i.e., a alleles but
not  A  alleles are transmitted). Likewise, let b2 and  c2
denote the corresponding numbers of informative trans-
missions in Study B. With complete genotype data, we
would compute the TDT by pooling the data:
We next show that, under the null hypothesis, the last
term in Eq. (1) has an expectation of 0. Let R1 = B1 + C1 >
0 (the capital letters denote the random variables), and R2
= B2 + C2 > 0. Under the null hypothesis, L(B1 | R1) ~
Binom(R1, 0.5), L(B2 | R2) ~ Binom(R2, 0.5), and B1 and
B2 are independent. We then have:
Therefore, under the null hypothesis, the pooled TDT sta-
tistic is nearly a weighted average of the corresponding
TDT statistics in the respective studies. The weights are
proportional to the number of informative parents (ni = bi
+ ci). Assuming that the two studies sampled comparable
populations (e.g., allele frequencies are similar at all loci),
we approximate these weights by the number of trios.
For a marker that is not genotyped in one study (but is
genotyped in the other), we try to impute the TDT statistic
using neighboring markers. We then add the observed
and imputed TDT scores from the two studies. Suppose M
markers have been genotyped by either Study A or Study
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B. Denote the physical locations of these markers by
{t1,...,tM}. Let   be a vector indicating
whether marker m is genotyped in Study A. Denote the
TDT statistics using each of the two samples as TDTA and
TDTB, respectively. Let fA(t) be the results of applying a
local linear regression fitting to (ti, TDTA) data. At each
marker, we compute:
In other words, if a marker is genotyped in Study A (vA =
1), we simply take the TDT statistic; if a marker ti is not
gentoyped in Study A, we impute its expected TDT statistic
using the predicted value. Similarly, we compute TB(t)
using data from Study B. The combined test statistic at
each marker is simply:
We implement the imputation step using the loess func-
tion in R. The choice of the smoothing parameter depends
on many factors such as the age of the disease mutation,
the population under study, and the marker density.
While an optimal window size is difficult to define, an
examination of inter-marker LD guides our choice: we
seek a region within which the genotyped markers are in
high LD. Roughly speaking, we are faced with a trade-off
between bias and variance: smoothing over a wide region
tends to reduce variance of the imputed statistics at the
cost of an increased bias. Therefore, an alternative to loess
with pre-specified bandwidth is a smoothing spline with
the degree of freedom chosen by cross-validation. To
properly account for the imputation, and to correct for
multiple comparison, we perform a simulation-based test:
conditioning on the parents' genotype, we generate the
transmitted and the non-transmitted haplotypes under
the null hypothesis, re-impute the TDT statistics, and
compute TDTcomb on the simulated data. The observed
maxiTDTcomb(ti) is compared with the null distribution of
the corresponding maxima in the simulated data.
Data set example
To illustrate our proposed method, we analyze Replicate 1
of the simulated RA data. This data set consists of 1500
nuclear families, each of which has both parents and two
affected children genotyped. It is known that there is a
strong effect of DR type at the HLA locus on chromosome
6. A simple TDT analysis using all 1500 families unambig-
uously demonstrates preferential transmission of DR-2 or
DR-3 alleles to the affected individuals. However, is the
DR allele the sole variant affecting the disease in the
region? To address this question, we examine the trans-
mission from parents who are homozygous 1/1 at the DR
locus. If the DR locus explains the entire association in the
region, conditioning on parents being 1/1, there should
not be preferential transmission at any markers nearby.
Among 1500 mothers, 70 have genotype 1/1. Our analy-
ses highlight a practical difficulty: performing stratified
analysis on a subset of samples further reduces the sample
size; thus, stratified analyses are particularly likely to suf-
fer from small sample size even when the main study has
good power.
On chromosome 6, we restrict ourselves to the 293 SNP
markers falling within 1.5 × 106 bp around the DR locus.
We consider a situation in which each third of the families
are genotyped on a different platform. The 293 SNPs are
randomly divided into three sets, and there is no overlap
in the three sets of markers or individuals. Because the risk
of RA is much higher among women, we hypothesize that
there may be gene × sex interaction. Furthermore, there
has been ambiguous evidence regarding maternally trans-
mitted risk elements [10]. Therefore, we looked at four
types of transmission: father to son, father to daughter,
mother to son, and mother to daughter. Because the phase
is known for all the affected children, the four types of
transmission can be examined independently. For each
type of transmission, we perform a TDT analysis on each
of the three subsets of families. Because the diagnosis of
RA is often ambiguous, we hypothesized that the more
severe cases are more likely to carry the genetic risk factor.
Therefore, a severity measure, on the scale of 1 to 5, is used
as a relative weight. We then combine the three sets of
TDT scores to compute TDTcomb, with a bandwidth
approximately 15 markers.
Results
The results of various TDT test for the mother-daughter
transmission in the 3-cM region are shown in Figure 1.
Figure 1a displays the TDT scores using each subset of
one-third of the families. Because the transmissions from
a mother to two daughters are independent, a meaningful
measure of sample size is the mother-daughter pairs. In
our data, the numbers of mother-daughter transmissions
in the three subsets are 46, 39, and 23, respectively. For all
TDT tests, we use 10,000 permutations to establish the
null distribution and significance level. The p-values of
TDT on the three subsets are 0.0011, 0.02, and 0.61,
respectively. In Figure 1b, the points represent the TDT
scores from subset A (families 1–500) and the solid line
represents the loess prediction,
. Figure 1c
compares the TDT scores when all markers are genotyped
in every individual (TDTall, open square) versus TDTcomb
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(filled points). While the maximum value achieved by
TDTcomb appears substantially lower than the correspond-
ing value by TDTall, the same is true under the null
hypothesis, because the imputed TDT statistics tend to be
smoother than observed ones. As a result, at a specific sig-
nificance level (say, 0.99), the critical value for TDTall is
17.38, while the corresponding critical value for TDTcomb
is 6.87. We perform a quantile transformation based on
the null distribution, and Figure 1d compares TDTall with
transformed TDTcomb. It indicates that, upon suitable
transformation, TDTcomb can achieve similar significance
level as if TDTall. However, the location of the peak shifts
slightly: while the marker with highest TDTall lies to the
right of the DR locus, that with the highest TDTcomb lies to
the left of DR locus. Another consequence of smoothing
and imputing TDT scores is that the "peak" of TDTcomb
appears somewhat narrower than TDTall. In a similar fash-
ion, we analyzed the other three types of transmission.
The results, summarized in Table 1, suggest the existence
of another variant that influences the disease risk. Interest-
ingly, transmission is distorted in mother-daughter and
father-daughter transmission, but not transmissions to
sons. This suggests possible gene × sex interaction. Finally,
while we set out to use severity as a relative weight for each
individual, retrospective comparison indicates that the
weight makes little difference.
TDT tests for mother-daughter transmissions, restricted to mothers with DR genotype 1/1 Figure 1
TDT tests for mother-daughter transmissions, restricted to mothers with DR genotype 1/1. a, TDT for three sub-
sets separately. Dotted vertical line indicates the location of DR locus. b, TDT scores using sub-sample A (square) versus 
imputed scores (line). c, TDT scores assuming all markers are genotyped in each individual (TDTall), open square) versus TDT-
comb. Dotted line indicates 0.01 critical value for TDTall, and solid line represents the corresponding critical value for TDTcomb. 
d, Comparison of TDTall and TDTcomb after a quantile transformation.BMC Proceedings 2007, 1(Suppl 1):S162 http://www.biomedcentral.com/1753-6561/1/S1/S162
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Discussion
We have performed additional simulations to assess the
gain in power of our combined test (not shown). In a
wide range of disease models and parameters, the com-
bined test achieves a greater power than the probability
that at least one of the two studies achieved statistical sig-
nificance, even though the latter procedure has an inflated
type I error. Furthermore, the gain in power of our
approach depends on marker density. In the current set-
ting, the entire SNP set on chromosome 6 has a density
comparable to a genome-wide set of 300 K, and hence
each of the three subsets we analyzed has a density com-
parable to the 100 K SNP array. When each subset of indi-
viduals has been genotyped on a denser marker set, the
imputed TDT scores tend to be more accurate. Thus, had
subsets of individuals been genotyped on different plat-
forms of 500 K SNP arrays, we would expect the imputed
TDT scores to be more accurate, and therefore combining
across studies will achieve even greater power. On the
other hand, compared to the pooled TDT with complete
marker data, the combined test incurs a loss of power.
This loss of power is to be expected for two reasons. First,
the smoothing process introduces uncertainties both
under the null and alternative hypotheses. Second, if a
locus increases the disease risk in both studies and the
high risk alleles are the same allele, the last term in Eq. (1)
has an expectation greater than 0; hence, E(TDTpool) >
E(TDTcomb).
We have developed and evaluated our approach in the
context of a family-based study using the TDT design. The
approach can be generalized to case-control design when
participants in all samples represent a relatively homoge-
neous population and all studies use the exact same phe-
notype definition. Combining samples in the presence of
population stratification requires extensions to our
method, including modification on the weight and the
smoothing parameters. For example, if LD among mark-
ers decays slower in one population than in the other, it
maybe desirable to use a wider smoothing parameter in
the former population. These issues should be examined
more thoroughly in the future. On the other hand, as long
as the cases and controls are matched within each study,
the combined test offers greater protection against popu-
lation stratification than a test on the pooled genotypes.
Finally, if different genetic factors underlie the etiology of
each study, combing these studies will not improve
power. Therefore, an important issue to address in the
future is how to decide whether different studies can be
combined.
Conclusion
Genome-wide association studies often suffer from insuf-
ficient sample size. The problem is exacerbated by the
need to restrict the analysis to a subset of individuals. Our
approach, which exploits the local LD structure without
assuming an explicit population model, opens up the pos-
sibility of improving statistical power by incorporating
existing data into future association studies.
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